GlassScriptPhysician profile
Jason Solway
NPI 1306229646
$2,869.71
in general payments reported to CMS, 2019-2025
24 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $577 · 2021: $144 · 2022: $208 · 2023: $562 · 2024: $306 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $556.98 | 2019-2023 | Tremfya |
| Abbvie INC. | $522.03 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $314.36 | 2019-2025 | |
| Genzyme Corporation | $203.16 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $155.37 | 2024-2025 | Sotyktu |
| Lilly USA, LLC | $154.83 | 2019-2025 | Ebglyss, Taltz |
| Sun Pharmaceutical Industries INC. | $115.57 | 2019-2023 | Winlevi, Ilumya |
| Pfizer INC. | $104.36 | 2019-2023 | |
| Leo Pharma INC. | $101.21 | 2019-2025 | Adbry |
| Incyte Corporation | $98.78 | 2022-2023 | Opzelura |
| Janssen Scientific Affairs, LLC | $94.51 | 2020 | |
| Ucb, INC. | $71.78 | 2021-2024 | Bimzelx |
| Amgen INC. | $61.02 | 2020-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $55.49 | 2020-2022 | |
| Arcutis Biotherapeutics, INC. | $43.44 | 2024-2025 | Zoryve |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $41.09 | 2019 | |
| Celgene Corporation | $37.10 | 2019 | |
| Krystal Biotech INC | $31.86 | 2024 | Vyjuvek |
| Epi Health, LLC | $25.06 | 2022 | |
| Dermavant Sciences, INC. | $20.48 | 2023 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.80 | 2020 | |
| Prugen, INC. Pharmaceuticals | $16.06 | 2020 | |
| Galderma Laboratories, L.P. | $15.46 | 2019 | |
| Organon LLC | $10.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Solway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.